Optical Coherence Tomography in Huntington's Disease—A Potential Future Biomarker for Neurodegeneration?

Optical Coherence Tomography in Huntington's Disease—A Potential Future Biomarker for Neurodegeneration?

Huntington's disease (HD) is a progressive neurodegenerative disorder for which, until now, only symptomatic treatment has been available. Lately, there have been multiple ongoing clinical trials targeting therapeutic agents for preventing disease onset or slowing disease progression in HD. The...

Full description

Saved in:
Bibliographic Details
Main Authors: Clancy Cerejo, Nicolas De Cleene, Elias Mandler, Katarina Schwarzová, Samuel Labrecque, Philipp Mahlknecht, Florian Krismer, Atbin Djamshidian, Klaus Seppi, Beatrice Heim
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Neurology International
Subjects:
Huntington's disease
optical coherence tomography
neurodegeneration
Online Access:https://www.mdpi.com/2035-8377/17/1/13
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items